Improving Functioning Among Aging Women Veterans

This study is testing a special type of talk therapy called Tailored Cognitive Behavioral Therapy for Menopause (CBT-Meno) for women veterans experiencing menopause symptoms. This therapy helps you learn ways to cope with common menopause symptoms and experiences. You may be able to join if you are a woman veteran aged 45 or older, receive care at the VA Maryland Healthcare System, have at least one moderate or two mild menopause symptoms, and can do telehealth appointments. The study aims to see how satisfied participants are with the therapy and how many people join and complete the study. The current recruitment status is unclear.

Study design
This is an interventional study planning to enroll 48 women. The phase of the study is not specified.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your satisfaction will be measured at post-treatment, around 12 weeks after starting. The study will also track recruitment for about 1.5 years and retention for about 2 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06580470

Improving Functioning Among Aging Women Veterans

Not Yet Recruiting
NAAges 45+InterventionalTreatment
VA Office of Research and Development
~48 participants
Updated 2025-09-11 on ClinicalTrials.gov
What's tested:Tailored Cognitive Behavioral Therapy for Menopause

At a glance

Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Client Satisfaction Questionnaire (CSQ-8)
Measured over Post-treatment, approximately 12 weeks
+5 more outcomes measured
Menopause
2 sites across 1 states
Maryland2
  • Haley Miles-McLean, PhD · PRINCIPAL_INVESTIGATOR · Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

female sex
45 years of age or older
currently receiving services at the VA Maryland Healthcare System
presence of at least one symptom rated "moderate" or above or two symptoms rated "mild" or above the Menopause Rating Scale (MRS)
ability to participate in telehealth appointments

Exclusion

are engaging in moderate-to-severe substance use that would impact their ability to participate and/or would require a higher level of care (as determined by chart review)
engagement in CBT-Meno, whether currently or in the past
participated in Aim 1 as a Veteran stakeholder
  • Client Satisfaction Questionnaire (CSQ-8)Post-treatment, approximately 12 weeks

    To examine acceptability, the investigators will collect satisfaction ratings via the Client Satisfaction Questionnaire (CSQ-8) at post-treatment assessment. The CSQ-8 contains eight Likert scale items that ask about quality of service received and if services have been helpful and provides an overall score. Reliability/validity for the measure is good. The minimum score is 8 and the maximum score is 32, with greater scores indicating more client satisfaction.

  • RecruitmentAt completion of study recruitment, approximately 1.5 years

    As a measure of feasibility, the investigators will evaluate recruitment by calculating the number of eligible participants (e.g., those that passed screening) divided by the number of potential participants that were approached for recruitment (# eligible ÷ # approached).

  • Retention RateFollowing completion of all intervention groups, approximately 2 years

    As a measure of feasibility, investigators will calculate retention rates defined as the percentage of enrolled participants who attend first 2 sessions ("engaged").

  • Outreach EffortsThroughout intervention delivery, approximately 2 years

    As a measure of feasibility, investigators will examine our study outreach efforts by calculating the mean number of reminders and outreach contacts made for each participant during the course of treatment.

  • Suitability of EligibilityAt completion of study recruitment, approximately 1.5 years

    As a measure of feasibility, the investigators will evaluate suitability of eligibility criteria by calculating the number of participants enrolled in the study divided by the number eligible (e.g., those that passed screening;# enrolled ÷ # eligible).

  • Adherence rateFollowing completion of all intervention groups, approximately 2 years

    As a measure of feasibility, investigators will calculate the adherence rate measured by treatment dropout percentages. This will be calculated as the number of participants who dropped out prior to completing treatment divided by the number who engaged (i.e., "engaged" = enrolled participants who attend first 2 sessions; #who dropped out prior to completing treatment ÷ # who engaged).